APA

Bright S. A., McElligott A. M., O'Connell J. W., O'Connor L., Carroll P., Campiani G., Deininger M. W., Conneally E., Lawler M., Williams D. C. & Zisterer D. M. (20100609). Novel pyrrolo-1,5-benzoxazepine compounds display significant activity against resistant chronic myeloid leukaemia cells in vitro, in ex vivo patient samples and in vivo. : British journal of cancer.

Chicago

Bright S A, McElligott A M, O'Connell J W, O'Connor L, Carroll P, Campiani G, Deininger M W, Conneally E, Lawler M, Williams D C and Zisterer D M. 20100609. Novel pyrrolo-1,5-benzoxazepine compounds display significant activity against resistant chronic myeloid leukaemia cells in vitro, in ex vivo patient samples and in vivo. : British journal of cancer.

Harvard

Bright S. A., McElligott A. M., O'Connell J. W., O'Connor L., Carroll P., Campiani G., Deininger M. W., Conneally E., Lawler M., Williams D. C. and Zisterer D. M. (20100609). Novel pyrrolo-1,5-benzoxazepine compounds display significant activity against resistant chronic myeloid leukaemia cells in vitro, in ex vivo patient samples and in vivo. : British journal of cancer.

MLA

Bright S A, McElligott A M, O'Connell J W, O'Connor L, Carroll P, Campiani G, Deininger M W, Conneally E, Lawler M, Williams D C and Zisterer D M. Novel pyrrolo-1,5-benzoxazepine compounds display significant activity against resistant chronic myeloid leukaemia cells in vitro, in ex vivo patient samples and in vivo. : British journal of cancer. 20100609.